Industry Verticals »

All Categories

Insights »

About TMR »

Pharmacovigilance Outsourcing Market

Pharmacovigilance Outsourcing Market (Service Type: Individual Case Safety Reports (ICSRs), Literature Monitoring, Aggregate Reporting (PSUR/PBRER, DSUR, etc.), Signal Detection & Risk Management, Risk Management Plans (RMP), Pharmacovigilance Audits & Training, Safety Database Hosting & Maintenance, Medical Device Vigilance, Regulatory & Compliance Support and Others; Therapeutic Area: Oncology, Neurology, Cardiology, Immunology, Respiratory, Infectious Diseases, Gastroenterology, Orthopedics & Musculoskeletal Disorders and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026–2036

Pharmacovigilance Outsourcing Market Outlook 2036

The global pharmacovigilance outsourcing market size was valued at USD 8.3 Billion in 2025 and is projected to reach USD 16.3 Billion by 2036, expanding at a CAGR of 6.3% from 2026 to 2036. The global pharmacovigilance outsourcing industry is primarily driven by the rising number of clinical trials and increasingly stringent global regulatory requirements for drug safety monitoring and adverse event reporting. Additionally, pharmaceutical and biotechnology companies are outsourcing pharmacovigilance activities to reduce operational costs, access specialized expertise, and manage the growing volume of adverse drug reaction data efficiently.

Market Size & Highlights

  • The pharmacovigilance outsourcing market reached USD 8.3 Billion in 2025.
  • The market is expected to climb to USD 16.3 Billion by 2036.
  • The pharmacovigilance outsourcing industry is anticipated to expand at a CAGR of 6.3% from 2026 to 2036.
  • Major companies in the market include Accenture, ArisGlobal, Biomapas, Capgemini, Cognizant etc.
  • North America dominated the market in 2025, holding the largest revenue share of 39.7%
  • By Therapeutic Area, Oncology segment accounted for the largest market share of 27.5% in 2025
Pharmacovigilance Outsourcing Market By Revenue

Analysts’ Viewpoint

The global pharmacovigilance outsourcing market is expanding rapidly as biopharmaceutical companies increasingly delegate drug safety monitoring and compliance activities to experienced external vendors and specialized service providers. The market growth driver results from increasing clinical trial activities which create higher requirements for adverse event reporting and safety surveillance that pharmaceutical companies must follow.

Pharmaceutical companies need to outsource their pharmacovigilance services as it helps them decrease their internal costs while vendors handle their complex case management and regulatory submission needs. The market faces challenges as different regions have different regulatory systems which create difficulties for standardizing processes and generate compliance problems for both sponsors and providers.

Safety reporting systems face increased operational expenses as data privacy regulations like GDPR and regional data localization requirements limit their ability to share data across borders. Midsize vendors face difficulties in expanding their services due to the existing lack of qualified pharmacovigilance specialists who can maintain service standards. The combination of artificial intelligence machine learning and automation technology enables organizations to create solutions that automate their case intake processes and literature screening functions and signal detection activities.

Vendors who develop cloud-based safety platforms with real-world evidence analytics capabilities will be able to meet the rising demand from developing markets which are expanding their clinical research operations. The global patient safety initiatives provide strong support for structural growth because they establish solid foundation for growth in all areas.

Pharmacovigilance Outsourcing Market Introduction

Pharmacovigilance outsourcing refers to the practice of pharmaceutical, biotechnology, and medical device companies delegating drug safety and adverse event monitoring activities to specialized third-party service providers. It includes services such as case processing, signal detection, risk management, medical review, aggregate reporting, regulatory compliance, and safety database management to ensure continuous monitoring of product safety throughout its lifecycle

Attribute Detail
Market Drivers
  • Rising volume of clinical trials & new drug approvals
  • Growing presence of CROs & BPOs globally

Rising volume of clinical trials & new drug approvals expected to drive pharmacovigilance outsourcing market size

The rising volume of clinical trials globally is significantly increasing demand for comprehensive pharmacovigilance outsourcing services across developed and emerging markets. The expansion of product pipelines by pharmaceutical and biotechnology companies results in higher safety monitoring requirements during both preclinical research and clinical development stages.

The safety data generated by each clinical trial needs to undergo organized processing of individual cases together with medical examination and signal identification and creation of documents that meet regulatory requirements. The increase in safety responsibilities which safety personnel need to handle creates excessive demands on resources together with infrastructure and technology systems and specialized personnel within sponsor organizations.

Companies can use outsourcing to handle their pharmacovigilance work as it provides access to specialized knowledge without the need to build their own operational systems and safety database. The growing number of new drug approvals creates a requirement for ongoing post-marketing surveillance combined with risk management development and scheduled safety update documentation. The regulatory authorities require new innovative therapies and biologics to report adverse events while maintaining worldwide compliance throughout their approval process. The development of biologics and biosimilars together with cell therapies and personalized medicines creates challenging and continuously changing needs for safety monitoring.

Small and mid-sized biotechnology companies particularly prefer outsourcing due to limited internal pharmacovigilance infrastructure and budget constraints. The global pharmacovigilance outsourcing market experiences continuous growth due to increasing number of clinical trials and the higher rate of new drug approvals.

Growing Presence of CROs & BPOs Globally Anticipated to Boost Pharmacovigilance Outsourcing Market Expansion

The growing presence of Contract Research Organizations (CROs) and Business Process Outsourcing (BPO) firms globally is significantly propelling the growth of the pharmacovigilance outsourcing market. These service providers deliver specialized drug safety solutions which include adverse event case processing and medical review and signal detection and risk management and regulatory reporting services.

The global expansion of CROs and BPOs enables pharmaceutical and biotechnology companies to find experienced pharmacovigilance workers who operate in various worldwide regions. The infrastructure of their system scales to support sponsors who need to handle different safety workloads without requiring them to spend on internal safety management systems and resources.

The Asia-Pacific region and other emerging markets offer outsourcing benefits as they combine lower costs with an expanding skilled workforce. Many providers now deliver comprehensive pharmacovigilance services which cover all aspects from clinical development until post-marketing surveillance.

Organizations achieve improved operational results through their continuous funding of advanced safety databases and automation tools and artificial intelligence systems. The outsourcing partners keep their knowledge current about global regulatory changes which enables them to ensure compliance with regulations across different countries. Strategic collaborations and long-term partnerships further strengthen trust and service continuity. The growing product pipeline and increasing global trials create a demand for CROs and BPOs that possess strong operational capacity and regulatory expertise which drives the pharmacovigilance outsourcing market to grow throughout the globe.

Attribute Detail
Market Opportunity
  • Integration of AI and automation into pharmacovigilance workflows

Integration of Artificial Intelligence and Automation into Pharmacovigilance Workflows Presents Significant Opportunity for Pharmacovigilance Outsourcing Market

The integration of artificial intelligence and automation into pharmacovigilance workflows is significantly transforming global drug safety operations and compliance management systems. Pharmaceutical firms begin to implement AI-based solutions which boost their capacity to conduct adverse event reporting with better performance and accuracy and larger operational reach.

The combination of machine learning algorithms with natural language processing tools enables automatic safety data extraction from both organized and unorganized data sources while performing data categorization and verification tasks. Robotic process automation handles repetitive tasks which include case intake and medical coding and database reconciliation and regulatory submission tracking.

The systems use these technologies to decrease the need for human work while they reduce the chance of errors made by people and they produce uniform records that all worldwide pharmacovigilance operations use. AI-powered signal detection systems analyze large volumes of clinical trial data, post-marketing surveillance information, and real-world evidence to identify emerging safety concerns earlier.

The use of automation enables organizations to meet regulatory requirements as it creates detailed audit records which support inspection processes and helps organizations complete their safety report submissions on schedule. Pharmaceutical and biotechnology clients can receive faster service delivery through outsourcing providers who utilize digital platforms which offer operational efficiency and budget-friendly service solutions and expandable pharmacovigilance services.

The combination of AI solutions with existing systems enables organizations to manage risks before they become problems while making important business choices. The process of intelligent automation implementation leads to higher productivity in operations while decreasing expenses over time and increasing patient safety results in every country around the globe.

Oncology Segment Driving Pharmacovigilance Outsourcing Market Growth

Pharmacovigilance Outsourcing Market By Type

By therapeutic area, the oncology segment with 27.5% global market share is significantly driving growth in the pharmacovigilance outsourcing market worldwide. The rise in global cancer cases has created a need for new oncology drugs which need thorough safety evaluation work to develop. The safety profiles of oncology therapies show complex patterns which require specialized pharmacovigilance work and ongoing monitoring operations.

The advanced treatments which include immunotherapies and targeted therapies and antibody drug conjugates need thorough evaluation of their adverse events. Oncology clinical trials produce large amounts of safety information which they collect from various patient groups throughout the globe. The outsourcing partners need to process large datasets as they require support in case processing and signal detection and risk management activities.

The regulatory authorities establish strict safety reporting rules for oncology products as these products cause extreme adverse reactions. The increasing need for pharmacovigilance outsourcing services comes from the expanding oncology pipelines together with the requirements for post-marketing surveillance.

Regional Outlook of Pharmacovigilance Outsourcing Market

Pharmacovigilance Outsourcing Market By Region
Attribute Detail
Leading Region
  • North America

North America is the dominant region in the pharmacovigilance outsourcing market, accounting for a considerable 39.7% market share. This is attributed to its well-established pharmaceutical and biotechnology industry, strong regulatory framework, and high drug development activity.

The region which includes the US holds a major portion of global clinical trials and new drug approvals which raises the need for tracking adverse events and conducting safety assessments. The U.S. Food and Drug Administration and other regulatory agencies enforce strict pharmacovigilance regulations that require organizations to establish effective safety monitoring systems. Pharmaceutical and biotech companies choose to work with outsourcing providers as they help them control their increasing safety data through efficient management of case processing and signal detection and risk assessment and regulatory submission tasks.

The region maintains its leadership position as it has major contract research organizations, advanced healthcare systems and it was one of the first areas to use AI-based pharmacovigilance systems. The rising biologics and oncology treatments and specialty drug markets create intricate safety monitoring requirements which result in increased demand for outsourcing services.

The strong understanding of drug safety standards and patient protection regulations results in continuous growth of pharmacovigilance services throughout North America which establishes the region as the leading market for global pharmacovigilance outsourcing services.

Analysis of Key Players in Pharmacovigilance Outsourcing Market

Accenture, ArisGlobal, Biomapas, Capgemini, Cognizant, ICON plc, IQVIA Inc., Parexel International, PrimeVigilance Ltd., ProPharma, Tata Consultancy Services Limited (TCS), United BioSource LLC, Wipro, and other prominent players are the key players governing the global Pharmacovigilance Outsourcing Market.

Each of these players has been profiled in the Pharmacovigilance Outsourcing market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In February 2026, ArisGlobal, recently announced the launch of NavaX Translation, a new solution delivered through a strategic partnership with TransPerfect Life Sciences to eliminate manual translation in global pharmacovigilance. NavaX Translation brings certified, pharma-grade translation and multilingual content directly into LifeSphere Safety workflows, enabling faster, more accurate, and fully compliant multilingual case processing at a global scale
  • In September 2025, ACL Digital announced the acquisition of Symbiance, a data-driven, technology-enabled Contract Research Organization (CRO) with over three decades of proven expertise in clinical data services and operations, medical monitoring, project management, medical writing, and pharmacovigilance segments. The acquisition of Symbiance by ACL Digital solidifies its position as an end-to-end provider of clinical research and data CRO solutions on a global scale.

Pharmacovigilance Outsourcing Market Snapshot

Attribute Detail
Size in 2025 USD 8.3 Billion
Forecast Value in 2036 More than USD 16.3 Billion
CAGR 6.3%
Forecast Period 2026-2036
Historical Data Available for 2021-2025
Quantitative Units USD Billion for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation By Service Type
  • Individual Case Safety Reports (ICSRs)
  • Literature Monitoring
  • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
  • Signal Detection & Risk Management
  • Risk Management Plans (RMP)
  • Pharmacovigilance Audits & Training
  • Safety Database Hosting & Maintenance
  • Medical Device Vigilance
  • Regulatory & Compliance Support
  • Others (Quality management, SOP development, etc.)
By Therapeutic Area
  • Oncology
  • Neurology
  • Cardiology
  • Immunology
  • Respiratory
  • Infectious Diseases
  • Gastroenterology
  • Orthopedics & Musculoskeletal Disorders
  • Others (Dermatology, Endocrinology, etc.)
By Service Provider
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPO) Providers
  • Specialized Pharmacovigilance Service Providers
  • Others (Software Vendors, etc.)
By End-user
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Research Organizations
  • Others (Government Agencies, etc.)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • Accenture
  • ArisGlobal
  • Biomapas
  • Capgemini
  • Cognizant
  • ICON plc
  • IQVIA Inc.
  • Parexel International
  • PrimeVigilance Ltd.
  • ProPharma
  • TATA Consultancy Services Limited
  • United BioSource LLC
  • Wipro
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global pharmacovigilance outsourcing market in 2025?

The global pharmacovigilance outsourcing market was valued at USD 8.3 Billion in 2025

What is the projected size of the pharmacovigilance outsourcing market by 2036?

The global pharmacovigilance outsourcing market is projected to cross USD 16.3 Billion by the end of 2036

What are the factors driving the pharmacovigilance outsourcing industry?

Rising volume of clinical trials & new drug approvals and growing presence of CROs & BPOs globally

What is the pharmacovigilance outsourcing market expected to grow during the forecast period?

The global pharmacovigilance outsourcing market is anticipated to grow at a CAGR 6.3% from 2026 to 2036

Which region is expected to dominate the pharmacovigilance outsourcing market during the forecast period?

North America is expected to account for the largest share from 2026 to 2036

Who are the prominent pharmacovigilance outsourcing providers?

Accenture, ArisGlobal, Biomapas, Capgemini, Cognizant, ICON plc, IQVIA Inc., Parexel International, PrimeVigilance Ltd., ProPharma, Tata Consultancy Services Limited (TCS), United BioSource LLC, Wipro, and other prominent players

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Pharmacovigilance Outsourcing Market
  4. Market Overview
    • Introduction
      • Segment Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Pharmacovigilance Outsourcing Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (US$ Bn)
  5. Key Insights
    • Healthcare Expenditure by Country/Region
    • Recent Technological Advancements
    • Regulatory Scenario across Key Countries / Regions
    • PORTER’s Five Forces Analysis
    • Consumer Behavior & End-User Insights
    • PESTLE Analysis
    • Key Industry Events
    • Go to Marketing Strategies for New Entrants
    • Pricing Analysis
    • Distributors Landscape
  6. Global Pharmacovigilance Outsourcing Market Analysis and Forecast, by Service Type
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Attractiveness Analysis, by Service Type
  7. Global Pharmacovigilance Outsourcing Market Analysis and Forecast, by Therapeutic Area
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Attractiveness Analysis, by Therapeutic Area
  8. Global Pharmacovigilance Outsourcing Market Analysis and Forecast, by Service Provider
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Attractiveness Analysis, by Service Provider
  9. Global Pharmacovigilance Outsourcing Market Analysis and Forecast, by End-user
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis, by End-user
  10. Global Pharmacovigilance Outsourcing Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region, 2021-2036
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness Analysis, by Region
  11. North America Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Value Forecast, by Country, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
      • By Country
  12. U.S. Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  13. Canada Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  14. Europe Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
      • By Country/Sub-region
  15. Germany Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  16. U.K. Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  17. France Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  18. Italy Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  19. Spain Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  20. The Netherlands Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  21. Rest of Europe Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  22. Asia Pacific Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • ASEAN
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
      • By Country/Sub-region
  23. China Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  24. India Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  25. Japan Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  26. South Korea Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  27. Australia Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  28. ASEAN Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  29. Rest of Asia Pacific Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  30. Latin America Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
      • By Country/Sub-region
  31. Brazil Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  32. Mexico Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  33. Argentina Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  34. Rest of Latin America Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  35. Middle East & Africa Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
      • By Country/Sub-region
  36. GCC Countries Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  37. South Africa Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  38. Rest of Middle East & Africa Pharmacovigilance Outsourcing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Service Type, 2021-2036
      • Individual Case Safety Reports (ICSRs)
      • Literature Monitoring
      • Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
      • Signal Detection & Risk Management
      • Risk Management Plans (RMP)
      • Pharmacovigilance Audits & Training
      • Safety Database Hosting & Maintenance
      • Medical Device Vigilance
      • Regulatory & Compliance Support
      • Others
    • Market Value Forecast, by Therapeutic Area, 2021-2036
      • Oncology
      • Neurology
      • Cardiology
      • Immunology
      • Respiratory
      • Infectious Diseases
      • Gastroenterology
      • Orthopedics & Musculoskeletal Disorders
      • Others
    • Market Value Forecast, by Service Provider, 2021-2036
      • Contract Research Organizations (CROs)
      • Business Process Outsourcing (BPO) Providers
      • Specialized Pharmacovigilance Service Providers
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Pharmaceutical Companies
      • Biotechnology Companies
      • Medical Device Manufacturers
      • Research Organizations
      • Others
    • Market Attractiveness Analysis
      • By Service Type
      • By Therapeutic Area
      • By Service Provider
      • By End-user
  39. Competition Landscape
    • Market Player - Competition Matrix (By Tier and Size of Companies)
    • Market Share Analysis, by Company (2025)
    • Company Profiles
      • Accenture
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • ArisGlobal
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Biomapas
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Capgemini
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Cognizant
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • ICON plc
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • IQVIA Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Parexel International
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • PrimeVigilance Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • ProPharma
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • TATA Consultancy Services Limited
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • United BioSource LLC
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Wipro
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments

List of Tables

Table 01: Global Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 02: Global Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 03: Global Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 04: Global Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 05: Global Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 06: North America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 07: North America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 08: North America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 09: North America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 10: North America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 11: U.S. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 12: U.S. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 13: U.S. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 14: U.S. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 15: Canada Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 16: Canada Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 17: Canada Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 18: Canada Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 19: Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 20: Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 21: Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 22: Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 23: Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 24: Germany Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 25: Germany Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 26: Germany Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 27: Germany Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 28: U.K. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 29: U.K. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 30: U.K. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 31: U.K. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 32: France Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 33: France Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 34: France Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 35: France Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 36: Italy Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 37: Italy Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 38: Italy Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 39: Italy Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 40: Spain Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 41: Spain Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 42: Spain Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 43: Spain Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 44: The Netherlands Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 45: The Netherlands Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 46: The Netherlands Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 47: The Netherlands Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 48: Rest of Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 49: Rest of Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 50: Rest of Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 51: Rest of Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 52: Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 53: Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 54: Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 55: Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 56: Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 57: China Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 58: China Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 59: China Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 60: China Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 61: Japan Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 62: Japan Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 63: Japan Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 64: Japan Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 65: India Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 66: India Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 67: India Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 68: India Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 69: South Korea Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 70: South Korea Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 71: South Korea Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 72: South Korea Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 73: Australia Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 74: Australia Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 75: Australia Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 76: Australia Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 77: ASEAN Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 78: ASEAN Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 79: ASEAN Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 80: ASEAN Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 81: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 82: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 83: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 84: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 85: Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 86: Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 87: Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 88: Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 89: Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 90: Brazil Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 91: Brazil Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 92: Brazil Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 93: Brazil Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 94: Mexico Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 95: Mexico Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 96: Mexico Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 97: Mexico Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 98: Argentina Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 99: Argentina Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 100: Argentina Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 101: Argentina Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 102: Rest of Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 103: Rest of Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 104: Rest of Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 105: Rest of Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 106: Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 107: Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 108: Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 109: Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 110: Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Country/Sub-region, 2021 to 2036
Table 111: GCC Countries Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 112: GCC Countries Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 113: GCC Countries Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 114: GCC Countries Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 115: South Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 116: South Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 117: South Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 118: South Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036
Table 119: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Type, 2021 to 2036
Table 120: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Therapeutic Area, 2021 to 2036
Table 121: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by Service Provider, 2021 to 2036
Table 122: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, by End-user, 2021 to 2036

List of Figures

Figure 01: Global Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 02: Global Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 03: Global Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 04: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Individual Case Safety Reports (ICSRs), 2021 to 2036
Figure 05: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Literature Monitoring, 2021 to 2036
Figure 06: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Aggregate Reporting (PSUR/PBRER, DSUR, etc.), 2021 to 2036
Figure 07: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Signal Detection & Risk Management, 2021 to 2036
Figure 08: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Risk Management Plans (RMP), 2021 to 2036
Figure 09: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Pharmacovigilance Audits & Training, 2021 to 2036
Figure 10: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Safety Database Hosting & Maintenance, 2021 to 2036
Figure 11: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Medical Device Vigilance, 2021 to 2036
Figure 12: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Regulatory & Compliance Support, 2021 to 2036
Figure 13: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 14: Global Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 15: Global Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 16: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Oncology, 2021 to 2036
Figure 17: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Neurology, 2021 to 2036
Figure 18: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Cardiology, 2021 to 2036
Figure 19: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Immunology, 2021 to 2036
Figure 20: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Respiratory, 2021 to 2036
Figure 21: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Infectious Diseases, 2021 to 2036
Figure 22: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Gastroenterology, 2021 to 2036
Figure 23: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Orthopedics & Musculoskeletal Disorders, 2021 to 2036
Figure 24: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 25: Global Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 26: Global Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 27: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Contract Research Organizations (CROs), 2021 to 2036
Figure 28: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Business Process Outsourcing (BPO) Providers, 2021 to 2036
Figure 29: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Specialized Pharmacovigilance Service Providers, 2021 to 2036
Figure 30: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 31: Global Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 32: Global Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 33: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Pharmaceutical Companies, 2021 to 2036
Figure 34: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Biotechnology Companies, 2021 to 2036
Figure 35: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Medical Device Manufacturers, 2021 to 2036
Figure 36: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Research Organizations, 2021 to 2036
Figure 37: Global Pharmacovigilance Outsourcing Market Revenue (USD Billion), by Others, 2021 to 2036
Figure 38: Global Pharmacovigilance Outsourcing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 39: Global Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 40: North America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 41: North America Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 42: North America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 43: North America Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 44: North America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 45: North America Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 46: North America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 47: North America Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 48: North America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 49: North America Pharmacovigilance Outsourcing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 50: North America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 51: U.S. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 52: U.S. Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 53: U.S. Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 54: U.S. Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 55: U.S. Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 56: U.S. Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 57: U.S. Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 58: U.S. Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 59: U.S. Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 60: Canada Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 61: Canada Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 62: Canada Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 63: Canada Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 64: Canada Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 65: Canada Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 66: Canada Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 67: Canada Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 68: Canada Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 69: Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 70: Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 71: Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 72: Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 73: Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 74: Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 75: Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 76: Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 77: Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 78: Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 79: Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 80: Germany Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 81: Germany Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 82: Germany Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 83: Germany Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 84: Germany Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 85: Germany Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 86: Germany Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 87: Germany Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 88: Germany Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 89: U.K. Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 90: U.K. Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 91: U.K. Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 92: U.K. Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 93: U.K. Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 94: U.K. Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 95: U.K. Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 96: U.K. Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 97: U.K. Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 98: France Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 99: France Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 100: France Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 101: France Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 102: France Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 103: France Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 104: France Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 105: France Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 106: France Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 107: Italy Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 108: Italy Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 109: Italy Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 110: Italy Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 111: Italy Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 112: Italy Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 113: Italy Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 114: Italy Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 115: Italy Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 116: Spain Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 117: Spain Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 118: Spain Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 119: Spain Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 120: Spain Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 121: Spain Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 122: Spain Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 123: Spain Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 124: Spain Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 125: The Netherlands Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 126: The Netherlands Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 127: The Netherlands Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 128: The Netherlands Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 129: The Netherlands Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 130: The Netherlands Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 131: The Netherlands Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 132: The Netherlands Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 133: The Netherlands Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 134: Rest of Europe Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 135: Rest of Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 136: Rest of Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 137: Rest of Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 138: Rest of Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 139: Rest of Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 140: Rest of Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 141: Rest of Europe Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 142: Rest of Europe Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 143: Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 144: Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 145: Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 146: Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 147: Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 148: Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 149: Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 150: Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 151: Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 152: Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 153: Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 154: China Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 155: China Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 156: China Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 157: China Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 158: China Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 159: China Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 160: China Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 161: China Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 162: China Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 163: Japan Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 164: Japan Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 165: Japan Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 166: Japan Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 167: Japan Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 168: Japan Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 169: Japan Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 170: Japan Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 171: Japan Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 172: India Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 173: India Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 174: India Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 175: India Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 176: India Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 177: India Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 178: India Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 179: India Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 180: India Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 181: South Korea Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 182: South Korea Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 183: South Korea Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 184: South Korea Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 185: South Korea Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 186: South Korea Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 187: South Korea Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 188: South Korea Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 189: South Korea Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 190: Australia Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 191: Australia Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 192: Australia Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 193: Australia Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 194: Australia Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 195: Australia Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 196: Australia Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 197: Australia Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 198: Australia Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 199: ASEAN Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 200: ASEAN Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 201: ASEAN Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 202: ASEAN Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 203: ASEAN Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 204: ASEAN Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 205: ASEAN Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 206: ASEAN Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 207: ASEAN Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 208: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 209: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 210: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 211: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 212: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 213: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 214: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 215: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 216: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 217: Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 218: Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 219: Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 220: Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 221: Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 222: Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 223: Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 224: Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 225: Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 226: Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 227: Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 228: Brazil Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 229: Brazil Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 230: Brazil Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 231: Brazil Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 232: Brazil Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 233: Brazil Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 234: Brazil Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 235: Brazil Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 236: Brazil Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 237: Mexico Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 238: Mexico Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 239: Mexico Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 240: Mexico Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 241: Mexico Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 242: Mexico Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 243: Mexico Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 244: Mexico Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 245: Mexico Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 246: Argentina Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 247: Argentina Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 248: Argentina Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 249: Argentina Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 250: Argentina Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 251: Argentina Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 252: Argentina Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 253: Argentina Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 254: Argentina Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 255: Rest of Latin America Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 256: Rest of Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 257: Rest of Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 258: Rest of Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 259: Rest of Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 260: Rest of Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 261: Rest of Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 262: Rest of Latin America Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 263: Rest of Latin America Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 264: Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 265: Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 266: Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 267: Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 268: Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 269: Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 270: Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 271: Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 272: Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 273: Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 274: Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 275: GCC Countries Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 276: GCC Countries Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 277: GCC Countries Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 278: GCC Countries Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 279: GCC Countries Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 280: GCC Countries Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 281: GCC Countries Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 282: GCC Countries Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 283: GCC Countries Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 284: South Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 285: South Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 286: South Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 287: South Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 288: South Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 289: South Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 290: South Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 291: South Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 292: South Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 293: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value (USD Billion) Forecast, 2021 to 2036
Figure 294: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Type, 2025 and 2036
Figure 295: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Type, 2026 to 2036
Figure 296: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Therapeutic Area, 2025 and 2036
Figure 297: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2026 to 2036
Figure 298: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by Service Provider, 2025 and 2036
Figure 299: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by Service Provider, 2026 to 2036
Figure 300: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Value Share Analysis, by End-user, 2025 and 2036
Figure 301: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Attractiveness Analysis, by End-user, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved

Pharmacovigilance Outsourcing Market

Buy This ReportBuy Now